As we work alongside incredible partners like Thermo Fisher Scientific, we are reminded of the power of collaboration in solving some of the biggest challenges in science and healthcare. As Katleen Verleysen wisely puts it, “To really be successful in these really big scientific challenges, you need to build an ecosystem. We are very fortunate to have the support of Thermo Fisher Scientific.” At miDiagnostics, we are grateful to play a role in advancing cell therapies through our work with Thermo Fisher Scientific. Together, we’re working on groundbreaking sterility testing for batch release and quality control in cell therapy manufacturing—helping to address the significant costs and time delays associated with these vital treatments. #Collaboration #Innovation #CellTherapy #Midiagnostics #ThermoFisher
I'm driven every day by our mission to enable customers to make the world cleaner, healthier, and safer. When it comes to making the world healthier, cell therapies are one of the most promising new modalities, but the time and cost to manufacture these lifesaving therapies are preventing them from realizing their full potential. It was a pleasure to sit down with Andrew Wilson and Katleen Verleysen in Davos to talk about what we're doing to help accelerate the time it takes to go from breakthrough to treatment and help make these life-changing therapies more accessible. One of the things I'm most excited about is our work with miDiagnostics to introduce groundbreaking sterility testing for batch release and related quality control tests, which is a game changer considering about 30-50% of cell therapy manufacturing costs are connected to quality control testing. Check our discussion below - Revolutionizing Cell Therapies: Innovative Technologies for A New Era of Personalized Medicine - CBS News